Inactive Instrument

Insiders ReShape Lifesciences Inc. Other OTC

Equities

RSLS

US7611236032

Insiders

Unlock all the news: Be the first to know and act before the market!

Reshape Lifesciences Announces Formation of International Scientific Advisory Board	23/23/23	CI
Reshape Lifesciences Inc. Appoints Nick Ansari, as Senior Vice President of Global Commercial Operations	24/22/24	CI
ReShape Lifesciences Appoints Paul F. Hickey as President and Member of the Board of Directors, Effective August 15, 2022	28/22/28	CI
ReShape Lifesciences Appoints Paul F. Hickey as Chief Executive Officer, Effective August 15, 2022	28/22/28	CI
ReShape Lifesciences Inc. Appoints Michael Bordainick as Senior Vice President, Commercial Operations	13/22/13	CI
Insider Trends: Insider 90-Day Selling Trend Extended at ReShape Lifesciences	22/21/22	MT
Obalon Therapeutics, Inc. has Changed its Name to ReShape Lifesciences Inc	16/21/16	CI
Obalon Therapeutics, Inc. Announces Resignation of David Moatazedi as Member of the Board, the Compensation Committee, and the Audit Committee	03/20/03	CI
Obalon Therapeutics, Inc. Appoints Kim Kamdar as Chairperson of the Board of Directors	01/20/01	CI
Obalon Therapeutics, Inc. Announces Management Changes	08/20/08	CI
Obalon Therapeutics, Inc. Appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer	24/19/24	CI
Obalon Therapeutics, Inc. Appoints Helmuth T. Billy as Medical Director	03/19/03	CI
ReShape Lifesciences Inc. Announces Resignation of Scott P. Youngstrom as Senior Vice President, Finance and Chief Financial Officer, Effective October 1, 2019	07/19/07	CI
Obalon Therapeutics, Inc. Appoints Bob MacDonald as Chief Retail Officer	10/19/10	CI
Obalon Therapeutics, Inc. Announces Management Changes	23/19/23	CI
ReShape Lifesciences Inc. Appoints Barton P. Bandy as President and Chief Executive Officer	02/19/02	CI
Dan W. Gladney to Resign as President and Chief Executive Officer of Reshape Lifesciences Inc., Effective as of March 31, 2019	28/19/28	CI
Obalon Therapeutics, Inc. Announces Promotion of Amy Vandenberg to Chief Clinical & Regulatory Affairs Officer	03/19/03	CI
Obalon Therapeutics, Inc. Announces Executive Changes	02/19/02	CI
Obalon Therapeutics, Inc. Announces Executive Appointments	02/18/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders ReShape Lifesciences Inc. Other OTC

Equities

RSLS

US7611236032

Insiders

Filters